Showing 1261-1270 of 1697 results for "".
Special Report: Cognitive Screening After COVID-19
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-cognitive-screening-after-covid-19/31791/Tools are needed for the assessment of neurologic and neuropsychologic sequelae of infection with the SARS-CoV-2 virus.Health Care Disparities in Alzheimer Disease Diagnosis and the Use of Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/health-care-disparities-in-alzheimer-disease-diagnosis-and-the-use-of-amyloid-targeting-treatments/36240/Disparities in Alzheimer disease care persist, and people from underrepresented racial, ethnic, or socioeconomic groups face considerable barriers to early diagnosis and access to disease-modifying anti-amyloid therapies.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31327/Thousands of neurologists gathered at the San Diego Convention Center from April 1-8 for the American Academy of Neurology’s (AAN) annual conference, fostering extensive collaboration across subspecialties. Among the key highlights were the release of four new evidence-based practice parameters for
- Lifting the Fog: How to Uncover the Cognitive Effects of AEDshttps://practicalneurology.com/columns/practice-management/lifting-the-fog-how-to-uncover-the-cognitive-effects-of-aeds/31142/Impact of Antiepileptic Drugs on Cognitive and Psychiatric Well-BeingIn the management of epilepsy and migraines, antiepileptic drugs (AEDs) play a crucial role in controlling symptoms. However, the long-term and often lifelong use of AEDs can lead to significant cognitive adverse events (CAE) and p
- Leaving AEDs Behind: When to Withdraw Therapy in Seizure-free Patientshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1008_04-pdf/30980/Managing Antiepileptic Drug (AED) Therapy in Seizure-Free Patients: Key ConsiderationsAchieving complete seizure control is the primary objective in epilepsy management, significantly improving patient quality of life. In specific epilepsy syndromes, such as benign rolandic epilepsy (childhood epile
- Six Burning Questions about Diabetic Neuropathyhttps://practicalneurology.com/columns/practice-management/six-burning-questions-about-diabetic-neuropathy/31023/Diabetic Neuropathies: Current Insights and Management StrategiesDiabetic neuropathies are the most prevalent forms of neuropathy globally, presenting significant challenges in clinical management and research. Despite advancements in understanding their clinical manifestations, critical aspects suc
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31022/Advancements in Transient Ischemic Attack Management: Insights from the FASTER StudyRecent research published in Practical Neurology highlights critical findings from the Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) study. This pilot clinical trial inv
- Is Earlier Better? What Do We Really Mean When We Advocate For Early DBS in Parkinson's Disease?https://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0408dbs-fea-pdf/31031/Early Deep Brain Stimulation in Parkinson’s Disease: Evaluating Benefits and RisksSince its introduction by Benabid et al. in the late 1980s, chronic deep brain stimulation (DBS) has become a widely accepted intervention for various neurological disorders, particularly Parkinson’s disease (PD). DBS
- Moving Past Conventional Wisdom in AD Therapyhttps://practicalneurology.com/columns/practice-management/moving-past-conventional-wisdom-in-ad-therapy/31124/Recent advancements in Alzheimer's Disease (AD) treatment are unveiling innovative approaches beyond traditional methods, as highlighted in Practical Neurology's latest News Briefs. Baxter International has reported promising outcomes from its phase II trial of gammagard IVIg, an immunomodulatory th
- A “Field Guide” to Mental Status Testinghttps://practicalneurology.com/diseases-diagnoses/imaging-testing/0105-feild-guide-pdf/31504/Streamlined Approaches to Evaluating Cognitive Impairment in Neurological PracticeEvaluating cognitive impairment is a common and complex task for practicing neurologists, encompassing a spectrum of conditions from delirium and post-stroke syndromes to various forms of dementia. The multitude of cog